Showing results (51-60 of 277) with videos related to

Sort By:
Pageof 28
Molecular Cancer|June 23, 2005
Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1Min Lin, Melinda M DiVito, Sofia D Merajver, et al.
American Journal of Clinical Oncology|June 1, 2002
Metastatic dedifferentiated chordoma with elevated beta-hCG: a case reportHidayatullah G Munshi, Sofia D Merajver, Riccardo Valdez, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2021
Engineered Tools to Study Intercellular CommunicationBenjamin A Yang, Trisha M Westerhof, Kaitlyn Sabin, et al.
Psycho-Oncology|July 25, 2012
Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk familiesMaria C Katapodi, Laurel L Northouse, Kara J Milliron, et al.
Cancer|May 27, 2010
Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancersMei Wu, Zhi-Fen Wu, Devin T Rosenthal, et al.
Plos One|May 3, 2013
Trends in breast cancer stage and mortality in Michigan (1992-2009) by race, socioeconomic status, and area healthcare resourcesTomi F Akinyemiju, Amr S Soliman, Glenn Copeland, et al.
BMC Systems Biology|October 6, 2011
Kinase inhibitors can produce off-target effects and activate linked pathways by retroactivityMichelle L Wynn, Alejandra C Ventura, Jacques A Sepulchre, et al.
The American Journal of Pathology|August 8, 2009
Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasiaXin Li, Maria E Gonzalez, Katherine Toy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 30, 2002
Health insurance and discrimination concerns and BRCA1/2 testing in a clinic populationEmily A Peterson, Kara J Milliron, Karen E Lewis, et al.
Oncology Nursing Forum|August 31, 2011
Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did notMaria C Katapodi, Laurel Northouse, Penny Pierce, et al.
Pageof 28